| Literature DB >> 32338621 |
Annet Wijnen1, Jildou Hoogland1, Tjerk Munsterman2, Carina LE Gerritsma3, Baukje Dijkstra4, Wierd P Zijlstra4, Johan S Dekker5, Janneke Annegarn6, Francisco Ibarra7, Geranda Ec Slager8, Wiebren Zijlstra9, Martin Stevens1.
Abstract
BACKGROUND: Recent technological developments such as wearable sensors and tablets with a mobile internet connection hold promise for providing electronic health home-based programs with remote coaching for patients following total hip arthroplasty. It can be hypothesized that such a home-based rehabilitation program can offer an effective alternative to usual care.Entities:
Keywords: home-based rehabilitation program; internet; osteoarthritis; physiotherapy; rehabilitation; remote coaching; tablet app; total hip arthroplasty; total hip replacement; usual care
Year: 2020 PMID: 32338621 PMCID: PMC7215512 DOI: 10.2196/14139
Source DB: PubMed Journal: JMIR Rehabil Assist Technol ISSN: 2369-2529
Baseline characteristics of the study population (N=42).
| Characteristic | Intervention group (n=15) | Control group 1 (n=15) | Control group 2 (n=12) | ||
| Gender: female, n (%) | 10 (67) | 10 (67) | 7 (58) | .85a | |
| Age (years), mean (SD) | 59.3 (3.6) | 59.3 (3.6) | 59.3 (5.3) | >.99b | |
| Body mass index (kg/m2), mean (SD) | 26.7 (5.1) | 28.0 (4.3) | 31.1 (6.5) | .10b | |
|
|
|
|
| .08b | |
|
| Low | 3 (20) | 7 (46) | 4 (33) |
|
|
| Medium | 6 (40) | 5 (33) | 8 (67) |
|
|
| High | 6 (40) | 3 (20) | 0 (0) |
|
|
|
|
|
| .58a | |
|
| Alone | 4 (27) | 2 (13) | 1 (8) |
|
|
| With partner and/or children | 11 (73) | 13 (87) | 11 (92) |
|
|
|
|
|
| .12a | |
|
| I or II | 13 (87) | 12 (80) | 6 (50) |
|
|
| III | 2 (13) | 3 (20) | 6 (50) |
|
| Exercise hoursd, median (range) | 17.9 | 6.0 | 2.5 | N/Ae | |
aFisher exact test.
bOne-way analysis of variance.
cASA: American Society of Anesthesiologists Physical Status Classification System.
dBased on 12 weeks of the program for the intervention group and 6 months postoperative for the control groups.
eN/A: not applicable.
Functional outcome measures at baseline of the study population (N=42).
| Measurement | Intervention group (n=15) | Control group 1 (n=15) | Control group 2 (n=12) | Odds ratio (95% CI)a | |||||||
| TUGb (seconds), mean (SD) | 11.3 (2.6) | 12.0 (4.6) | 13.2 (5.3) | 0.92 (0.77-1.10) | .33 | ||||||
| FTSSTc (seconds), mean (SD) | 16.2 (3.0) | 20.8 (6.6) | 23.8 (11.0) | 0.83 (0.70-1.00) | .04 | ||||||
|
|
|
|
|
|
| ||||||
|
| Pain | 48.9 (12.8) | 35.5 (14.8) | 36.3 (18.4) | 1.12 (1.03-1.23) | .03 | |||||
|
| Other symptoms | 50.0 (18.2) | 29.3 (13.1) | 41.7 (19.5) | 1.07 (1.01-1.13) | .03 | |||||
|
| Function in ADLe | 52.7 (17.5) | 34.0 (10.2) | 37.1 (19.1) | 1.14 (1.03-1.27) | .02 | |||||
|
| Function in sport and recreational activities | 23.3 (13.7) | 16.3 (10.0) | 20.8 (22.1) | 1.04 (0.98-1.11) | .16 | |||||
|
| Hip-related quality of life | 19.2 (10.7) | 22.9 (12.9) | 24.5 (13.5) | 0.98 (0.93-1.03) | .43 | |||||
|
|
|
|
|
|
| ||||||
|
| Physical functioning | 42.7 (14.4) | 28.0 (15.2) | 24.6 (19.1) | 1.07 (1.01-1.13) | .02 | |||||
|
| Role limitations: physical | 33.3 (40.8) | 20.0 (36.8) | 14.6 (24.9) | 1.01 (0.99-1.03) | .16 | |||||
|
| General health perception | 80.9 (12.8) | 67.9 (17.4) | 51.6 (25.5) | 1.08 (1.01-1.16) | .03 | |||||
aConditional logistic regression.
bTUG: Timed Up & Go test.
cFTSST: Five Times Sit-to Stand Test.
dHOOS: Hip disability and Osteoarthritis Outcome Score; scale of 0-100 (0 = extreme symptoms, 100 = no symptoms).
eADL: activities in daily living.
fSF-36: 36-item Short Form Health Survey; scale of 0-100 (higher score = better perceived health or functioning).
Objective outcome measures of the study population (N=42).
| Measurement | Intervention group (n=15) | Control group 1 (n=15) | Control group 2 (n=12) | Odds ratio (95% CI)a | ||
|
|
|
|
|
|
| |
|
| T1c | 10.5 (2.1) | 14.8 (4.0) | 13.3 (3.9) | 0.68 (0.48-0.97) | .04 |
|
| T2d | 8.0 (1.0) | 10.3 (2.6) | 10.0 (3.4) | 0.34 (0.14-0.84) | .02 |
|
| T3e | 7.5 (1.0) | 9.02 (1.9) | 8.9 (2.5) | 0.33 (0.13-0.86) | .02 |
|
|
|
|
|
|
| |
|
| T1 | 14.9 (2.9) | 21.3 (4.5) | 17.7 (3.5) | 0.75 (0.56-1.00) | .05 |
|
| T2 | 12.6 (1.9) | 16.7 (2.4) | 14.9 (3.1) | 0.49 (0.24-0.99) | .05 |
|
| T3 | 11.7 (1.5) | 14.7 (2.5) | 14.0 (2.4) | 0.56 (0.31-0.99) | .05 |
aResults of conditional logistic regression, corrected for baseline.
bTUG: Timed Up & Go test.
cT1: 4 weeks.
dT2: 12 weeks.
eT3: 6 months.
fFTSST: Five Times Sit-to-Stand Test.
Mean (SD) of self-reported outcome measures of the study population (N=42).
| Measure | Intervention group (n=15) | Control group 1 (n=15) | Control group 2 (n=12) | Odds ratio (95% CI)a | |||
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
| |
|
|
| T1c | 88.8 (7.6) | 71.7 (17.1) | 73.5 (15.9) | 1.24 (0.93-1.64) | .14 |
|
|
| T2d | 94.0 (3.4) | 87.9 (10.7) | 78.5 (16.6) | 1.19 (0.98-1.45) | .09 |
|
|
| T3e | 98.7 (2.1) | 85.1 (12.5) | 85.6 (11.3) | 1.29 (0.94-1.77) | .12 |
|
|
|
|
|
|
|
| |
|
|
| T1 | 75.3 (13.2) | 68.0 (18.9) | 62.1 (14.1) | 1.03 (0.97-1.09) | .33 |
|
|
| T2 | 82.3 (10.0) | 78.7 (15.8) | 74.6 (13.1) | 1.04 (0.96-1.13) | .37 |
|
|
| T3 | 91.0 (6.0) | 76.3 (13.0) | 77.5 (17.7) | 1.10 (1.00-1.21) | .06 |
|
|
|
|
|
|
|
| |
|
|
| T1 | 76.5 (8.0) | 60.6 (17.0) | 58.1 (15.3) | 1.22 (0.94-1.57) | .13 |
|
|
| T2 | 92.8 (8.5) | 79.0 (11.3) | 69.7 (14.8) | 1.24 (0.99-1.55) | .06 |
|
|
| T3 | 96.8 (3.6) | 80.0 (15.6) | 79.1 (15.6) | 1.25 (0.94-1.67) | .13 |
|
|
|
|
|
|
| ||
|
|
| T1 | 70.0 (18.8) | 26.7 (20.1) | 29.7 (24.3) | 1.10 (1.01-1.20) | .04 |
|
|
| T2 | 76.3 (20.5) | 63.8 (26.1) | 49.1 (21.6) | 1.04 (1.00-1.07) | .04 |
|
|
| T3 | 82.5 (11.6) | 59.6 (19.3) | 64.9 (24.1) | 1.09 (1.01-1.17) | .03 |
|
|
|
|
|
|
|
| |
|
|
| T1 | 50.8 (15.1) | 45.8 (18.3) | 43.2 (19.5) | 1.04 (0.99-1.10) | .11 |
|
|
| T2 | 75.4 (14.8) | 71.3 (19.7) | 63.0 (21.4) | 1.03 (0.99-1.07) | .21 |
|
|
| T3 | 88.8 (8.9) | 71.3 (20.2) | 69.3 (22.5) | 1.09 (1.02-1.17) | .02 |
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
| |
|
|
| T1 | 54.8 (15.9) | 41.1 (20.2) | 36.3 (20.6) | 1.04 (1.00-1.08) | .09 |
|
|
| T2 | 86.0 (6.8) | 62.6 (19.2) | 538 (18.0) | 1.30 (0.89-1.91) | .17 |
|
|
| T3 | 89.0 (7.1) | 65.0 (18.9) | 59.2 (20.8) | 1.26 (0.99-1.60) | .07 |
|
|
|
|
|
|
|
| |
|
|
| T1 | 20.0 (34.3) | 23.3 (29.1) | 6.3 (15.5) | 1.01 (0.99-1.04) | .35 |
|
|
| T2 | 70.0 (42.5) | 38.3 (42.1) | 37.5 (34.5) | 1.04 (1.00-1.08) | .04 |
|
|
| T3 | 93.3 (25.8) | 56.7 (44.8) | 45.8 (39.7) | 1.04 (1.00-1.08) | .03 |
|
|
|
|
|
|
|
| |
|
|
| T1 | 83.1 (15.3) | 77.4 (15.9) | 66.9 (17.3) | 1.00 (0.94-1.07) | .91 |
|
|
| T2 | 86.1 (13.5) | 73.9 (20.8) | 63.0 (22.2) | 1.05 (0.97-1.13) | .26 |
|
|
| T3 | 84.8 (21.5) | 72.6 (14.8) | 63.4 (31.8) | 1.01 (0.97-1.07) | .57 |
aConditional logistic regression adjusted for baseline for comparison of the two control groups and intervention group.
bHOOS: Hip disability and Osteoarthritis Outcome Score; scale of 0-100 (0 = extreme symptoms, 100 = no symptoms).
cTI: 4 weeks.
dT2: 12 weeks.
eT3: 6 months.
fADL: activities in daily living.
gSF-36: 36-item Short Form Health Survey; scale of 0-100 (higher score = better perceived health or functioning).
Cohen d (95% CI) based on mean (SD) functional measure values corrected for baseline.
| Measurement | Twelve weeks | Six months | |||
|
|
| Intervention group vs control group 1 | Intervention group vs control group 2 | Intervention group vs control group 1 | Intervention group vs control group 2 |
| TUGa | 0.7 (–0.1-1.4) | 0.6 (–0.2-1.4) | |||
| FTSSTc | 0.6 (–0.2-1.3) | 0.5 (–0.3-1.3) | |||
|
|
|
|
|
| |
|
| Pain | 0.6 (–0.2-1.3) | |||
|
| Other symptoms | 0.0 (–0.7-0.7) | 0.5 (–0.3-1.2) | ||
|
| Function in ADLe | ||||
|
| Function in sport and recreational activities | 0.5 (0.2-1.3) | |||
|
| Hip-related quality of life | 0.2 (–0.5-0.9) | 0.6 (–0.2-1.4) | ||
|
|
|
|
|
| |
|
| Physical functioning | ||||
|
| Role limitations: physical | ||||
|
| General health perception | 0.2 (–0.5-0.9) | 0.2 (–0.6-0.9) | 0.1 (–0.6-0.8) | –0.1 (–0.8-0.7) |
aTUG: Timed Up & Go test.
bEffect sizes of d>0.80 are in bold.
cFTSST: Five Times Sit-to-Stand Test.
dHOOS: Hip disability and Osteoarthritis Outcome Score.
eADL: activities in daily living.
fSF-36: 36-item Short Form Health Survey.